SEC Form D · Amendment · filed September 21, 2021
MBF Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Aris M. Persidis · Ambler, PADirectorChristopher M. Cashman · Ambler, PADirectorDhiren M. Thakker · Ambler, PADirectorChris M. Bunge · Ambler, PADirectorThomas Tillett · Ambler, PAExec · DirectorGin N. Chao · Grand Cayman, Cayman IslandsDirectorSherwin D. Jannat · New York, NYDirectorJohn D. Rutledge · New York, NYExec · DirectorJames Martin · San Diego, CADirectorAndrew Pellett · Portsmouth, NHDirectorRakesh Narasimhan · Seattle, WADirectorMarian Joh · Seattle, WAExec · DirectorWilliam Christy · Bangor, MEDirectorNathan A. Lutz · Uniontown, PADirectorZachary K. Ellis · Pittsburgh, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗